Full approval, which requires six months of data, would allow Pfizer-BioNTech to begin marketing the vaccine.
"I think it's going to be time for somebody else to have this job in a year from now," White House Press Secretary Jen Psaki said.Pharmaceutical companies usually guard their intellectual property closely. But Stéphane Bancel said a waiver wouldn't affect the company financially.Slow global COVID-19 vaccination rates are raising concerns that worse variants of the coronavirus could be percolating, ready to rip into the world before herd immunity can diminish their impact.
617, a variant first detected in India that may be linked to the surge in cases there now."We were lucky because we vaccinated ahead of the onslaught [of the U.K. strain]. Otherwise we would have been in trouble. That's the superspreader strain," Topol says.Schiffer agrees partial herd immunity is causing the level of new infections in the U.S. to drop despite the highly infectious B.1.1.7's prevalence.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Canada Authorizes Pfizer-BioNTech Covid-19 Vaccine for Children 12 to 15 Years OldCanada authorized use of the Pfizer-BioNTech Covid-19 vaccine for children between the ages of 12 and 15, making it the first Western economy to permit the shot for people under 16
Read more »
Pfizer, BioNTech to donate COVID-19 vaccines to Olympic athletesPfizer and BioNTech will be providing COVID-19 vaccines to Olympic athletes participating in the summer games in Tokyo.
Read more »
Pfizer, BioNTech to provide Covid-19 vaccine to Olympic athletesInitial doses are expected to be delivered to participating delegations at the end of May with the goal of ensuring the delegations receive second doses ahead of arrivals in Tokyo.
Read more »
Pfizer seeks full FDA approval for COVID-19 vaccineBREAKING: Pfizer and partner BioNtech announce they are starting the process to seek full FDA approval in the U.S. for their COVID-19 vaccine.
Read more »
Pfizer/BioNTech seek full FDA approval for their Covid-19 vaccinePfizer/BioNTech seeks full FDA approval for its Covid-19 vaccine, which is currently available through an emergency use authorization
Read more »